Article Versions Notes

Borisevich SS, Aksinina TE, Ilyina MG, Shender VO, Anufrieva KS, Arapidi GP, Antipova NV, Anizon F, Esvan YJ, Giraud F, et al. The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells. Cancers. 2024; 16(4):834. https://doi.org/10.3390/cancers16040834

Borisevich, Sophia S., Tatiana E. Aksinina, Margarita G. Ilyina, Victoria O. Shender, Ksenia S. Anufrieva, Georgij P. Arapidi, Nadezhda V. Antipova, Fabrice Anizon, Yannick J. Esvan, Francis Giraud, and et al. 2024. "The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells" Cancers 16, no. 4: 834. https://doi.org/10.3390/cancers16040834

Borisevich, S. S., Aksinina, T. E., Ilyina, M. G., Shender, V. O., Anufrieva, K. S., Arapidi, G. P., Antipova, N. V., Anizon, F., Esvan, Y. J., Giraud, F., Tatarskiy, V. V., Moreau, P., Shakhparonov, M. I., Pavlyukov, M. S., & Shtil, A. A. (2024). The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells. Cancers, 16(4), 834. https://doi.org/10.3390/cancers16040834